News
September 2010
Dr. Christer Wingren of the Dept. of Immunotechnology is a partner in the new Phast-ID project supported by a grant from the EU 7th framework programme that will develop a photonic crystal-based disposable biosensor for use in point-of-care diagnostic applications.
May 14, 2015
Prof. Mats Ohlin was today awarded a grant from the National Institute of Health through a project entitled Antigenic determinants of asthma-associated allergens for design of immunotherapy headed by Dr. Anna Pomés (INDOOR Biotechnologies Inc.).
March 13, 2007
The Knut and Alice Wallenberg Foundation granted a consortium at Lund University headed by the Department of Immunotechnology 25 MSEK to fund acquisition of equipment for use in genomic and proteomic studies of cancer.
Biotech builder award to Professor Carl Borreback
Carl Borrebaeck, Professor at Department of immunotechnology, has been granted the prestigious BiotechBuilders Award for his pioneering medical research and role as entrepreneur within Life Science as co-founder to SanzaGen, Immunovia, Alligator Bioscience and BioInvent. The award was given at the annual BiotechBuilders event in Stockholm the 28th [...]
November 19, 2013
Senior investigators at the Dept. of Immunotechnology presented their research at the Cancer Research Open House day arranged to present cancer research activities within Lund University departments located at Medicon Village.
May 28, 2015
U-READ, the Unit for Rapid Engineered Antibody Development, at the Department of Immunotechnology was today accepted as an integrated part of SciLifeLab's Drug Discovery and Development platform (press release).
February 19, 2011
The Breast Cancer Initiative, a part of the interdisciplinary cancer centre Create Health headed by Prof. Carl Borrebaeck of the Dept. of Immunotechnology, was awarded 25 MSEK from the Swedish innovation agency Vinnova.
October 8, 2010
The Department celebrated the 20th anniversary of the inauguration of Immunotechnology at Lund University.
September 10, 2012
Dr. Johan Malmström has received an ERC starting grant amounting to 1.5 million € from the European Science Council for his proteomics research on Streptococci in terms of a project entitled "In vivo pathogen profiling using selected reaction monitoring".
November 3, 2015
Researchers in Stockholm, Uppsala, Linköping and Lund, including Prof. Carl Borrebaeck of the Dept. of Immunotechnology today argued in favor of more increased funding for development of personalized medicine in Sweden